Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Burrows

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nature Reviews. Urology|June 4, 2021
Hypoxia-inducible factor 2 inhibitors show promise in advanced kidney cancerNatalie Burrows, Patrick H Maxwell
Experimental Cell Research|March 17, 2017
Hypoxia and B cellsNatalie Burrows, Patrick Henry Maxwell
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
Inhibiting the phosphatidylinositide 3-kinase pathway blocks radiation-induced metastasis associated with Rho-GTPase and Hypoxia-inducible factor-1 activityNatalie Burrows, Brian Telfer, Georg Brabant, et al.
Journal of Thyroid Research|July 19, 2011
Hypoxia-inducible factor in thyroid carcinomaNatalie Burrows, Muhammad Babur, Julia Resch, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2011
GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathwaysNatalie Burrows, Muhammad Babur, Julia Resch, et al.
Scientific Reports|March 15, 2016
Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)Natalie Burrows, Gaelle Cane, Mathew Robson, et al.
Journal of Medicinal Chemistry|May 25, 2012
Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenograftsRoben G Gieling, Muhammad Babur, Lupti Mamnani, et al.
Kidney International|May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factorSerafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
Oncotarget|March 19, 2016
Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinomaRafia S Al-Lamki, Jun Wang, Jun Yang, et al.
Oncotarget|August 17, 2016
Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomasNatalie Burrows, Joseph Williams, Brian A Telfer, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nature Reviews. Urology|June 4, 2021
Hypoxia-inducible factor 2 inhibitors show promise in advanced kidney cancerNatalie Burrows, Patrick H Maxwell
Experimental Cell Research|March 17, 2017
Hypoxia and B cellsNatalie Burrows, Patrick Henry Maxwell
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
Inhibiting the phosphatidylinositide 3-kinase pathway blocks radiation-induced metastasis associated with Rho-GTPase and Hypoxia-inducible factor-1 activityNatalie Burrows, Brian Telfer, Georg Brabant, et al.
Journal of Thyroid Research|July 19, 2011
Hypoxia-inducible factor in thyroid carcinomaNatalie Burrows, Muhammad Babur, Julia Resch, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2011
GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathwaysNatalie Burrows, Muhammad Babur, Julia Resch, et al.
Scientific Reports|March 15, 2016
Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)Natalie Burrows, Gaelle Cane, Mathew Robson, et al.
Journal of Medicinal Chemistry|May 25, 2012
Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenograftsRoben G Gieling, Muhammad Babur, Lupti Mamnani, et al.
Kidney International|May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factorSerafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
Oncotarget|March 19, 2016
Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinomaRafia S Al-Lamki, Jun Wang, Jun Yang, et al.
Oncotarget|August 17, 2016
Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomasNatalie Burrows, Joseph Williams, Brian A Telfer, et al.
Pageof 2